Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jun;11(3):208-14.
doi: 10.1007/s11916-007-0192-6.

Update on pharmacotherapy guidelines for treatment of neuropathic pain

J Mark Wallace  1
Affiliations
Review

Update on pharmacotherapy guidelines for treatment of neuropathic pain

J Mark Wallace. Curr Pain Headache Rep. 2007 Jun.

Abstract

Neuropathic pain encompasses a myriad of painful disease states that are often hard to treat, especially with one single medication. In the comprehensive treatment of neuropathic pain, the concept of complex polypharmacy is a rational approach, accompanied by physical and mental health therapies. Medications primarily used for neuropathic pain generally fall into the categories of anticonvulsants, antidepressants, opioids, and topical agents. Generally, most first-line medications used today show a response rate of approximately 30% to 50% reduction in pain in up to 50% of patients treated. There is no "gold standard" in regard to one medication for neuropathic pain. Some new medications have emerged during the past few years that help to augment the armamentarium of medications used in neuropathic pain. This paper reviews the definition of neuropathic pain and introduces the reader to the evidence-based literature on these new medications available for the treatment of neuropathic pain.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Pain. 2005 Apr;6(4):253-60 - PubMed
    1. Med Lett Drugs Ther. 2005 Sep 12;47(1217):75-6, 73 - PubMed
    1. J Am Osteopath Assoc. 2005 Sep;105(9 Suppl 4):S12-9 - PubMed
    1. Drug News Perspect. 2003 Nov;16(9):622-30 - PubMed
    1. N Engl J Med. 2005 Mar 31;352(13):1373-5 - PubMed

MeSH terms

LinkOut - more resources